Age Related Macular Degeneration News and Research

RSS

NEI highlights new technologies and tools to help people living with low vision or blindness

During Low Vision Awareness Month, the National Eye Institute (NEI), part of the National Institutes of Health, is highlighting new technologies and tools in the works to help the 4.1 million Americans living with low vision or blindness.

6 Feb 2017

Researchers develop cell culture model that could help develop early treatment strategies for AMD

An international team from the University of Alabama at Birmingham and University College London and Queens University Belfast in the United Kingdom developed a cell culture model that could help to develop earlier treatment strategies for age-related macular degeneration, the third most prevalent cause of vision loss worldwide.

3 Feb 2017

VisionCare receives FDA approval to begin clinical study of telescope implant in post-cataract patients

VisionCare, Inc. ("VisionCare"), a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), today announced the U.S. Food and Drug Administration (FDA) approved the company's investigational device exemption for a new U.S. clinical study.

12 Jan 2017

New imaging technique could revolutionize assessment of eye health and disease

Researchers at the University of Rochester Medical Center have developed a new imaging technique that could revolutionize how eye health and disease are assessed.

3 Jan 2017

New book provides insights into latest treatments for partial blindness

In Restoring Low Vision, renowned neuroscientist Bernhard Sabel explains cutting-edge science in language that patients can easily understand and provides a comprehensive look at the latest treatments for partial blindness.

15 Dec 2016

TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage

A common class of drugs for vision loss may actually add to the problem in some patients, according to new research co-led by scientists at The Scripps Research Institute (TSRI).

7 Dec 2016

Persavita’s flagship natural eye health product Saffron 2020 receives U.S. patent

Persavita Inc. is pleased to announce the successful issue of the United States patent for its flagship natural eye health product, Saffron 2020.

23 Nov 2016

Research provides new insight into possible causes of AMD among older people

Research from the University of Southampton gives new insight into possible causes of Age-related Macular Degeneration (AMD), a leading cause of vision loss among people aged 50 and older.

21 Nov 2016

Gut microbiota may play important role in influencing onset of blinding wet AMD

Age-related Macular Degeneration (AMD) is the leading cause of irreversible blindness in the industrialized world, affecting over 10 million individuals in North America.

15 Nov 2016

Discovery of novel protein could lead to potential new treatments for age-related retinal disease

The discovery of a novel protein that links aging and age-dependent retinal diseases could lead to potential new treatments for conditions that cause sight loss in later life.

15 Nov 2016

Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Second Sight Medical Products, Inc. (Second Sight or the Company), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing the initial human proof of concept for the ongoing development of the Company's Orion™ I Visual Cortical Prosthesis (Orion I).

1 Nov 2016

Clinical study results reveal long-term safety of gene transfer to treat macular degeneration

The long-term safety of gene transfer to treat neovascular age-related macular degeneration (NVAMD), and the production of two therapeutic proteins encoded by those genes for at least 2.5 years in the eyes of patients with advanced NVAMD are demonstrated in the results of a clinical trial published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

20 Oct 2016

Healthy fruit-rich Mediterranean diet may help protect against macular degeneration

People who closely follow the Mediterranean diet - -especially by eating fruit -- may be more than a third less likely to develop age-related macular degeneration, a leading cause of blindness, according to a study presented today at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology.

17 Oct 2016

Age Related Macular Degeneration News and Research

NEI highlights new technologies and tools to help people living with low vision or blindness

Researchers develop cell culture model that could help develop early treatment strategies for AMD

VisionCare receives FDA approval to begin clinical study of telescope implant in post-cataract patients

New imaging technique could revolutionize assessment of eye health and disease

New book provides insights into latest treatments for partial blindness

TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage

Persavita’s flagship natural eye health product Saffron 2020 receives U.S. patent

Research provides new insight into possible causes of AMD among older people

Gut microbiota may play important role in influencing onset of blinding wet AMD

Discovery of novel protein could lead to potential new treatments for age-related retinal disease

Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Clinical study results reveal long-term safety of gene transfer to treat macular degeneration

Healthy fruit-rich Mediterranean diet may help protect against macular degeneration

Encapsulated cell therapy could be new way to fight glaucoma

UEF research shows retinal changes may be detected earlier than brain changes

Research findings offer promising treatment target for blinding diseases

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

Gentle combination of FDA-approved drugs could combat photoreceptor degeneration in mice

RPB continues research initiative to address urgent needs in treating low vision

Research opens way towards making promising advances in retinal prostheses

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News